Skip to main content
. Author manuscript; available in PMC: 2023 Apr 14.
Published in final edited form as: Adv Oncol. 2021 May 19;1:29–39. doi: 10.1016/j.yao.2021.02.003

FIG. 4.

FIG. 4

Coronal CT slice of a patient with lung cancer. Dose distribution of (A) respiratory gated treatment in which the tumor is tracked and (B) conventional free-breathing treatment with larger treatment margins. (C) Dose difference between the tracked treatment versus the conventional treatment. (From Menten MJ, Fast MF, Nill S, et al. Lung stereotactic body radiotherapy with an MR-linac – Quantifying the impact of the magnetic field and real-time tumor tracking. Radiother. Oncol. 2016;119:461–466.; with permission. (Figure 4 in original).)